Nahdi Medical Company · TADAWUL:4164
Nahdi Medical — Q3 2024 Earnings Presentation
17 slides from Nahdi Medical's earnings presentation, 2024
Slide 1: Investor Presentation Q3 2024
Nahdi Medical Company INVESTOR PRESENTATION Q3 2024 = — — j : ~ Oy = &
Slide 2: Resilient Financial Performance
RESILIENT FINANCIAL PERFORMANCE Revenue 2.35bn (+8.8%) 2.16bn Gross Profit 851mn (36.2%) 879mn (40.6%) Net Profit 182mn (7.7%) 213mn (9.8%) Revenue 7.08bn (+9.0%) 6.49bn Gross Profit 2.65bn (37.4%) 2.67bn (41.1%) Net Profit 663mn (9.4%) 722mn (11.1%) STRONG CASH FLOW Capex ZERO DEBT DPS GENERATION 3
Slide 3: 100 mn + 1 mn +
#1 140+ To be the most loved & trusted health and wellbeing partner for all our Guests pharmacy chain cities In KSA with 1,162 stores serving 97% of KSA population 100mn+ 80%+ Guests / yr of Revenue To exceed all our Guests’ expectations by served across pharmacies Generated by Nuhdeek Guests provid
Slide 4: Invested in the success of our people
Invested in the success of our people Always cultivating Saudi talents More than 500K hours Strong Partnerships of training conducted annually 24 Universities. providing 2,000+ training opportunities Human Resource Development Fund 2nd in GCC in 2023. Among the top company in Saudi, GCC and Asia for
Slide 5: Stronger brand equity YoY
Stronger brand equity YoY Nielsen Store Equity Index ** 80%+ of revenue generated from Nahdi “Nuhdeek” Guests* ~1mn new Nuhdeek Guests* Source: Company disclosure, Nielsen * By End of Q3 2024 **Methodology used to identify the brand equity of pharmacies and underlying drivers based on brand saliency
Slide 6: Voice of the Supplier
Voice of the Supplier Nahdi Medical Company | Q3 2024EARNINGS CALL Benchmark Performance by Engagement Driver & Business 65 Area 59 56 42 41 37 Nahdi Panda Otheim Danube Aldawaa — Lulu og se S seo ae
Slide 7: Nahdi's Social Sustainability Pillars
Nahdi's Social Sustainability Pillars Yesterday CHRONIC DISEASE MANAGEMENT Involves the ongoing care and support provided to members of our communities with long- term medical conditions such as diabetes and hypertension. At Nahdi we aim to optimize health outcomes, improve quality of life, and redu
Slide 8: LogiSYM Retail Asia awards
LogiSYM Retail asia Store Retail best warehouse Initiative of the automation Year
Slide 9: Strategic Initiatives
(5 Strategic Initiatives
Slide 10: Quarterly growth and investment in strategic initiatives
Quarterly Growth YOY +10.8% Investing into evolving consumer trends +8.8% +8.8% +16,900 23.3% Revenue New SKUs added E-commerce +7.2% Q3 24 vs. Q3 23 in 9M 2024 contribution (from 15.8% in Q3 23) Efficient OPEX management +3.6% 1.2% Improvement OPEX as % of revenue not impacted by outlays in new ini
Slide 11: Nahdi's expanding regional network: UAE
Nahdi’s expanding regional network UAE Performance Presence in 5 Emirates in the UAE Reach a total of 23 pharmacies Ras Alkhaimah The UAE witnessed 158% revenue growth in 9M 2024 Services Available ▪ Nahdi Online Sharjah ▪ Nahdi Global Dubai ▪ E-pharmacist Ajman Abu Dhabi
Slide 12: Evolve into a national healthcare player
Evolve into a national healthcare player Healthcare Performance ▪ Revenue 105% growth in 9M 2024 ▪ 4 matured polyclinics are profit-generating delivering a combined net margin of 15%+ ▪ Total Healthcare business reported Positive bottom line, despite opening 3 new polyclinics in Madinah, Yanbu & Naj
Slide 13: Revenue
Pharmacies Revenue in 9M grew 9.0% YoY & 1,148 1,152 1,086 1,120 1,105 1,185 8.8% in Q3 driven by a strong Clinics 2 2 3 6 5 9 performance in the Retail business SAR mn 9.0% Strong performance of Nahdi’s fast-growing businesses, with 9M YoY revenue from Healthcare up 105% and from the UAE up 158%. R
Slide 14: Margin Gross Profit
Margin Gross margin at 37.4%, Gross profit Gross 41.0% 40.9% 41.1% 40.4% 41.1% 37.4% declined slightly by 0.7% SAR mn - The continues investments to support the sales performance generated solid topline growth. - Accelerated growth in strategic business channels i.e. Online, Gross Profit Healthcare
Slide 15: Revenue Net Profit
Net Profit/ Revenue 9.8% 10.1% 10.3% 10.2% 11.1% 9.4% Net profit of SAR 663 million, reflecting a 9.4% margin - Operating expenses efficiency SAR mn shows 1.3% improvement in operating expenses as % of revenue, despite the investments in key strategic initiatives i.e. network expansion, healthcare,
Slide 16: Revenue EBITDA
Revenue EBITDA/ 16.9% 18.7% 18.6% 18.1% 19.0% 17.1% Highly profitable business SAR mn Consistently delivering best in class retail EBITDA margin in line with the guidance. Amount -2.1% Source: Company disclosure
Slide 17: Thank You
THANK YOU Contacts: Investor Relations Department Email IR@nahdisa Website: httos//investors.nahdisa/ P.O. Box 17129 Jeddah 21484, Saudi Arabia
Nahdi Medical Company — Q3 2024 Earnings Presentation on 6ix